|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.53(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$25.5 - $41.09 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
187,281 |
290,198 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,236,561 |
$12,063,571 |
Total People Sold |
1 |
1 |
15 |
16 |
Total Sell Transactions |
3 |
3 |
33 |
58 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wicki Andreas |
Director |
|
2013-06-05 |
4 |
S |
$30.00 |
$75,000 |
I/I |
(2,500) |
2,120,874 |
|
- |
|
Wicki Andreas |
Director |
|
2013-06-04 |
4 |
S |
$30.31 |
$394,030 |
I/I |
(13,000) |
2,123,374 |
|
- |
|
Wicki Andreas |
Director |
|
2013-06-03 |
4 |
S |
$30.00 |
$57,000 |
I/I |
(1,900) |
2,136,374 |
|
- |
|
Evnin Luke |
Director |
|
2013-06-03 |
4 |
AS |
$30.00 |
$2,462,160 |
I/I |
(82,072) |
824,255 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-31 |
4 |
AS |
$30.00 |
$298,050 |
I/I |
(9,935) |
906,327 |
|
- |
|
Wicki Andreas |
Director |
|
2013-05-31 |
4 |
AS |
$30.00 |
$90,990 |
I/I |
(3,033) |
2,138,274 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-30 |
4 |
AS |
$30.00 |
$1,337,460 |
I/I |
(44,582) |
916,262 |
|
- |
|
Wicki Andreas |
Director |
|
2013-05-30 |
4 |
AS |
$30.00 |
$75,000 |
I/I |
(2,500) |
2,141,307 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-29 |
4 |
AS |
$30.00 |
$612,330 |
I/I |
(20,411) |
960,844 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-28 |
4 |
AS |
$30.62 |
$6,039,523 |
I/I |
(195,117) |
981,255 |
|
- |
|
Wicki Andreas |
Director |
|
2013-05-22 |
4 |
AS |
$30.00 |
$554,130 |
I/I |
(18,471) |
2,143,807 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-22 |
4 |
AS |
$30.00 |
$220,200 |
I/I |
(7,340) |
1,176,372 |
|
- |
|
Wicki Andreas |
Director |
|
2013-05-20 |
4 |
AS |
$30.00 |
$431,220 |
I/I |
(14,374) |
2,162,278 |
|
- |
|
Evnin Luke |
Director |
|
2013-05-20 |
4 |
AS |
$30.00 |
$406,500 |
I/I |
(13,550) |
1,183,712 |
|
- |
|
Hastings Paul J |
Director |
|
2013-05-15 |
4 |
B |
$29.30 |
$24,993 |
D/D |
853 |
853 |
2.39 |
- |
|
Evnin Luke |
Director |
|
2013-04-24 |
4 |
AS |
$30.04 |
$189,342 |
I/I |
(6,303) |
1,163,486 |
|
- |
|
Wicki Andreas |
Director |
|
2013-04-24 |
4 |
AS |
$30.04 |
$12,045 |
I/I |
(401) |
2,176,652 |
|
- |
|
Evnin Luke |
Director |
|
2013-04-23 |
4 |
AS |
$30.00 |
$3,243,450 |
I/I |
(108,115) |
1,169,789 |
|
- |
|
Wicki Andreas |
Director |
|
2013-04-23 |
4 |
AS |
$30.00 |
$469,380 |
I/I |
(15,646) |
2,177,053 |
|
- |
|
Stack David M |
President and CEO |
|
2013-04-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
987 |
|
- |
|
Evnin Luke |
Director |
|
2013-04-15 |
4 |
AS |
$30.00 |
$77,250 |
I/I |
(2,575) |
1,277,904 |
|
- |
|
Wicki Andreas |
Director |
|
2013-04-15 |
4 |
AS |
$30.00 |
$192,020 |
I/I |
(6,400) |
2,192,699 |
|
- |
|
Evnin Luke |
Director |
|
2013-04-12 |
4 |
S |
$29.30 |
$100,089 |
I/I |
(3,416) |
1,314,255 |
|
- |
|
Evnin Luke |
Director |
|
2013-04-12 |
4 |
OE |
$2.69 |
$100,046 |
I/I |
37,192 |
1,317,671 |
|
- |
|
Evnin Luke |
Director |
|
2013-04-12 |
4 |
AS |
$30.00 |
$300,000 |
I/I |
(10,000) |
1,280,479 |
|
- |
|
781 Records found
|
|
Page 27 of 32 |
|
|